TIMOTHY SHEW: Open Payments
NPI 1760014757 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 24 payments from 12 companies in 2025. Trend: 2023 $370 · 2024 $539 · 2025 $627
Food & beverage: $590Education: $36
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $233 |
| Astellas Pharma US Inc | 4 | $77 |
| Pharmacosmos Therapeutics Inc. | 2 | $45 |
| Rigel Pharmaceuticals, Inc. | 2 | $43 |
| Coherus Oncology, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| GENZYME CORPORATION | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| ABBVIE INC. | 1 | $31 |
| Eisai Inc. | 1 | $20 |
Products named: RYBREVANT, Vyloy, MONOFERRIC, TAVALISSE, LOQTORZI, EPKINLY, DARZALEX, Lenvima.
Industry payments across NE — which companies pay providers there.
